30% off. Use code SUMMERSALE30 at checkout for 30% off for 12 months on Plus, Pro and Premium subscriptions. Subscribe now

Rob Hershberg

Track

Insider profile

Currently holds positions in Fate Therapeutics Inc, Adaptive Biotechnologies Corp and NanoString Technologies Inc

Performance

Overall performance
2.4
Performance over holding periods
2.4
30 days 90 days 120 days
Average return -5% 8.2% 15.1%
Success rate 41% 68% 82%
Transactions
6 0% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance

Positions

Position Company Period
Director Fate Therapeutics Inc May 1, 2020 -
Independent Director Adaptive Biotechnologies Corp Feb. 1, 2013 -
Independent Director NanoString Technologies Inc March 2, 2015 -
Chief Scientific Officer Celgene Corp Jan. 8, 2016 - April 28, 2016
Rob Hershberg's trades of Adaptive Biotechnologies Corp's stock


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2025-12-12 2025-12-10
S Sale
98,918 -26.0%
286.00
US$3,388,263 		98,918 -26.0% 286.00 US$3,388,263
2025-12-10 2025-12-10
PrS Proposed sale
97,903
27.69
US$815,402 		97,903 27.69 US$815,402
2025-03-12 2025-03-12
PrS Proposed sale
10,622
293.25
US$2,984,498 		10,622 293.25 US$2,984,498
2025-03-12 2025-03-12
S Sale
53,000 -43.2%
7.59
US$402,270 		53,000 -43.2% 7.59 US$402,270
2025-02-12 2025-02-11
US Hillevax Inc (HLVX)
S Sale
11,901 -1.1%
1.76
US$21,003 		11,901 -1.1% 1.76 US$21,003
2025-02-12 2025-02-04
US Hillevax Inc (HLVX)
S Sale
14,634 -1.3%
1.89
US$27,658 		14,634 -1.3% 1.89 US$27,658
2024-02-12 2024-02-08
US Hillevax Inc (HLVX)
S Sale
11,597 -1.2%
14.93
US$173,161 		11,597 -1.2% 14.93 US$173,161
2024-01-22 2024-01-22
US Hillevax Inc (HLVX)
PrS Proposed sale
72,000
14.00
US$1,008,000 		72,000 14.00 US$1,008,000
2022-06-06 2022-06-03
S Sale
672 -25.1%
22.75
US$15,288 		672 -25.1% 22.75 US$15,288
2021-04-19 2021-04-15
PlS Planned sale
118 -5.9%
74.20
US$8,756 		118 -5.9% 74.20 US$8,756
2021-04-19 2021-04-15
PlS Planned sale
19 -0.9%
72.87
US$1,385 		19 -0.9% 72.87 US$1,385
2021-04-19 2021-04-15
PlS Planned sale
7 -0.3%
71.75
US$502 		7 -0.3% 71.75 US$502
2021-03-17 2021-03-15
PlS Planned sale
1,214 -39.1%
67.16
US$81,532 		1,214 -39.1% 67.16 US$81,532
2021-03-17 2021-03-15
PlS Planned sale
282 -8.3%
66.03
US$18,620 		282 -8.3% 66.03 US$18,620
2021-03-17 2021-03-15
PlS Planned sale
4 -0.1%
63.58
US$254 		4 -0.1% 63.58 US$254
2021-03-10 2021-03-08
PlS Planned sale
2,000 -57.1%
44.56
US$89,120 		2,000 -57.1% 44.56 US$89,120
2021-03-10 2021-03-08
PlS Planned sale
2,000 -100.0%
44.56
US$89,120 		2,000 -100.0% 44.56 US$89,120
2021-02-18 2021-02-16
PlS Planned sale
69 -3.5%
83.93
US$5,791 		69 -3.5% 83.93 US$5,791
2021-02-18 2021-02-16
PlS Planned sale
163 -7.7%
82.83
US$13,501 		163 -7.7% 82.83 US$13,501
2021-02-18 2021-02-16
PlS Planned sale
156 -6.8%
81.79
US$12,759 		156 -6.8% 81.79 US$12,759
2021-02-18 2021-02-16
PlS Planned sale
159 -6.5%
80.55
US$12,807 		159 -6.5% 80.55 US$12,807
2021-02-18 2021-02-16
PlS Planned sale
323 -11.7%
79.53
US$25,688 		323 -11.7% 79.53 US$25,688
2021-02-18 2021-02-16
PlS Planned sale
318 -10.3%
78.40
US$24,931 		318 -10.3% 78.40 US$24,931
2021-02-17 2021-02-16
PlS Planned sale
2,000 -57.1%
65.45
US$130,900 		2,000 -57.1% 65.45 US$130,900
2021-01-20 2021-01-15
PlS Planned sale
622 -100.0%
67.05
US$41,705 		622 -100.0% 67.05 US$41,705
2021-01-20 2021-01-15
PlS Planned sale
1,378 -68.9%
66.34
US$91,417 		1,378 -68.9% 66.34 US$91,417
2021-01-19 2021-01-15
PlS Planned sale
90 -4.5%
74.55
US$6,710 		90 -4.5% 74.55 US$6,710
2021-01-19 2021-01-15
PlS Planned sale
291 -12.8%
73.66
US$21,435 		291 -12.8% 73.66 US$21,435
2021-01-19 2021-01-15
PlS Planned sale
410 -15.3%
72.91
US$29,893 		410 -15.3% 72.91 US$29,893
2021-01-19 2021-01-15
PlS Planned sale
709 -20.9%
71.77
US$50,885 		709 -20.9% 71.77 US$50,885
2020-12-16 2020-12-15
PlS Planned sale
241 -100.0%
57.01
US$13,739 		241 -100.0% 57.01 US$13,739
2020-12-16 2020-12-15
PlS Planned sale
1,759 -87.9%
55.78
US$98,117 		1,759 -87.9% 55.78 US$98,117
2020-12-16 2020-12-15
PlS Planned sale
812 -30.1%
69.88
US$56,743 		812 -30.1% 69.88 US$56,743
2020-12-16 2020-12-15
PlS Planned sale
688 -20.3%
68.68
US$47,252 		688 -20.3% 68.68 US$47,252
2020-11-18 2020-11-16
PlS Planned sale
746 -28.3%
47.03
US$35,084 		746 -28.3% 47.03 US$35,084
2020-11-18 2020-11-16
PlS Planned sale
754 -22.2%
46.31
US$34,918 		754 -22.2% 46.31 US$34,918
2020-11-18 2020-11-16
PlS Planned sale
223 -100.0%
48.41
US$10,795 		223 -100.0% 48.41 US$10,795
2020-11-18 2020-11-16
PlS Planned sale
1,777 -88.8%
47.60
US$84,585 		1,777 -88.8% 47.60 US$84,585
2020-10-16 2020-10-15
PlS Planned sale
2,000 -100.0%
51.51
US$103,020 		2,000 -100.0% 51.51 US$103,020
2020-10-16 2020-10-15
PlS Planned sale
1,023 -35.1%
39.54
US$40,449 		1,023 -35.1% 39.54 US$40,449
2020-10-16 2020-10-15
PlS Planned sale
477 -14.1%
38.93
US$18,570 		477 -14.1% 38.93 US$18,570
2020-09-17 2020-09-15
PlS Planned sale
163 -7.9%
44.20
US$7,205 		163 -7.9% 44.20 US$7,205
2020-09-17 2020-09-15
PlS Planned sale
1,337 -39.4%
43.55
US$58,226 		1,337 -39.4% 43.55 US$58,226
2020-09-16 2020-09-15
PlS Planned sale
2,000 -100.0%
42.58
US$85,160 		2,000 -100.0% 42.58 US$85,160
2020-08-19 2020-08-17
PlS Planned sale
240 -11.3%
39.26
US$9,422 		240 -11.3% 39.26 US$9,422